Experimental cancer drug begins first human tests in china
NCT ID NCT06806046
Summary
This is an early safety study testing a new cancer drug called M9140 in Chinese patients with advanced colorectal cancer that has stopped responding to standard treatments. The trial will enroll 12 participants to check if the drug is safe and to see early signs of whether it might help control the cancer. This is a Phase 1 study, meaning it's the first time this specific drug is being tested in people in China.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beijing Cancer Hospital
Beijing, China
-
The Second Affiliated Hospital of Zhejiang University School of Medicine
Hangzhou, China
-
The Sixth Affiliated Hospital of Sun Yat-sen University
Guangzhou, China
Conditions
Explore the condition pages connected to this study.